Duodenal Ulcer Clinical Trial
Official title:
A Study to Investigate the Preventive Effect of AG-1749 Against the Recurrence of Gastric And Duodenal Ulcers During Long-Term Treatment With Low Dose Aspirin.
The purpose of this study is to determine whether lansoprazole, once daily (QD), compared to gefarnate, twice daily (BID), is effective in preventing the recurrence of gastric and duodenal ulcers in patients receiving long term treatment with low dosage aspirin.
In Japan, low-dose aspirin is one of the commonly prescribed drugs for inhibiting thrombosis
and thrombus formation after angina, myocardial infarction, ischemic cerebrovascular
disease, coronary artery by-pass surgery and percutaneous transluminal coronary angioplasty
in patients. While low-dose aspirin is effective in these cases, its use sometimes causes
gastric and duodenal ulcers which can lead to gastrointestinal bleeding, and in worse cases
may lead to death.
The purpose of this study is to assess the efficacy of lansoprazole versus gefarnate in
patients with a history of gastric or duodenal ulcers receiving daily low dose aspirin
therapy.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01435525 -
Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
|
N/A | |
| Completed |
NCT00284908 -
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00952978 -
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)
|
Phase 3 | |
| Completed |
NCT01964131 -
BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT01452724 -
Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer
|
Phase 3 | |
| Recruiting |
NCT01037491 -
Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets
|
N/A | |
| Completed |
NCT00595517 -
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
|
Phase 3 | |
| Completed |
NCT00953381 -
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)
|
Phase 2 | |
| Completed |
NCT05010954 -
Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
|
Phase 3 | |
| Completed |
NCT01199536 -
Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers
|
N/A | |
| Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
| Recruiting |
NCT03057171 -
A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA
|
||
| Completed |
NCT01568398 -
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
|
Phase 3 | |
| Completed |
NCT02423187 -
Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
|
||
| Completed |
NCT00543868 -
MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
|
Phase 2 | |
| Completed |
NCT03553563 -
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
|
Phase 3 | |
| Completed |
NCT05208268 -
A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
|
||
| Active, not recruiting |
NCT04702542 -
To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.
|
N/A | |
| Completed |
NCT00173953 -
Lymphocytic Subsets and Cytokine Production With H. Pylori Infection
|
N/A | |
| Completed |
NCT00132171 -
Helicobacter Pylori Eradication With a New Sequential Treatment
|
Phase 3 |